Dutasteride before prostate laser surgery and recovery outcomes
Treatments studied
Part of Kidney & urinary clinical trials.
This study looks at whether taking dutasteride for at least 6 months before prostate laser surgery affects surgery results and recovery. It includes men having a specific type of prostate surgery called HoLEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 80 years old.
- You have an enlarged prostate (BPH) and are scheduled for HoLEP surgery.
- You either have taken dutasteride (0.5 mg daily) for at least 6 months before surgery, or have not taken a similar medication (5-ARI) in the last year.
- Your medical records are complete and available in the hospital system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anxious and scared men feel before two common prostate surgeries: HoLEP and TURP. It aims to better understand these feelings and help patients in the future.
This study looks at how long patients should keep a urinary catheter (a tube that drains urine) after having laser surgery to remove prostate tissue. Researchers want to understand what timing works best for patients who couldn't urinate before surgery.
This study measures how your lungs work during a minimally invasive prostate procedure called HoLEP. Researchers want to understand breathing changes during surgery to improve safety and comfort for future patients.
This trial compares three different laser methods for removing prostate tissue in men with an enlarged prostate (BPH). It aims to find which approach works best while being safe and effective.
This trial looks at whether doing a prostate “laser procedure” (called HoLEP) before starting radiation and hormone therapy can improve severe urinary symptoms and reduce urine retention problems. It is for people with prostate cancer who are planning radiation plus hormone treatment and who have significant bladder/urinary trouble.
This study measures how much prostate tissue is removed during a minimally invasive laser surgery (HoLEP) and tests whether the amount removed can predict how much your urinary symptoms improve. Understanding this connection may help doctors better predict surgery outcomes for men with urinary problems.
Hear when a new Prostatic Hyperplasia, Benign trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.